The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug.
Cytokinetics Inc. scored U.S. FDA marketing clearance Dec. 19 for Myqorzo (aficamten) 5-mg, 10-mg, 15-mg, and 20-mg tablets to improve functional capacity and symptoms in adults with symptomatic ...
The Wegovy pill is one of two oral GLP-1 drugs expected to hit the market in the next few months; the other, from Lilly, is called orforglipron – until it receives a brand name – and is expected to be ...
Cytokinetics announced the FDA approval of aficamten to improve functional capacity and symptoms in adults with symptomatic ...
The U.S. Food and Drug Administration said on Friday it has granted national priority vouchers to Merck's cholesterol pill ...
Aficamten, a first-in-class cardiac myosin inhibitor, offers a new treatment option for symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Clinical trials SEQUOIA-HCM and MAPLE-HCM showed ...
Verywell Health on MSN
6 Potential Risks of Taking Too Much Vitamin E
Taking high-dose vitamin E supplements long-term can cause serious side effects like bleeding, stroke, and heart failure. Learn safe dosing and warning signs.
Mexico manufactures medical devices and medicines, but the majority are exported, leaving residents facing shortages.
MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCMFDA Approval Based on ...
Verywell Health on MSN
8 Medications That Can Interact With Your Daily Multivitamin
While generally safe, multivitamins can change how other medications work, affect how much medication gets absorbed into your bloodstream, or create unwanted nutrient buildup.
With over four years of experience writing in the housing market space, Robin Rothstein demystifies mortgage and loan concepts, helping first-time homebuyers and homeowners make informed decisions as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results